LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
BCIQ Data Coverage
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
3rd Biotech CEO & Investor Reception
East-West Biopharma Summit 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
Isu Abxis Co. Ltd.
Headquarters:
Seongnam, South Korea
Website:
https://www.abxis.com/eng/i...
Year Founded:
2001
Status:
Public
Industry Sector:
HealthTechnology
CEO:
Yup Hwang, MBA
Number Of Employees:
190
Enterprise Value:
$130,312,580
PE Ratio:
6.41
Exchange/Ticker 1:
KOSDAQ:086890
Exchange/Ticker 2:
N/A
Latest Market Cap:
$149,850,351
BioCentury
|
Jun 4, 2022
Product Development
New modalities give HER3 another shot at ASCO
ASCO data from Daiichi, Merus show anti-HER3 efficacy in challenging indications
Read More
BioCentury
|
Jun 22, 2018
Clinical News
Antibodies neutralize Catalyst's Factor IX variant
Read More
BioCentury
|
Jun 18, 2018
Clinical News
Antibodies neutralize Catalyst's Factor IX variant, crater stock
Read More
BioCentury
|
Sep 19, 2016
Company News
Catalyst Biosciences hematology news
Read More
BioCentury
|
Apr 6, 2015
Company News
Catalyst Biosciences, Targacept deal
Read More
BioCentury
|
Oct 14, 2013
Company News
Catalyst Biosciences, Isu Abxis deal
Read More
BioCentury
|
Oct 14, 2013
Finance
Highlights of weekly biotech stock moves
Regulatory, clinical and other milestones
Read More
BioCentury
|
Oct 9, 2013
Company News
Catalyst, Isu Abxis partner for Catalyst's Factor IX
Read More
Items per page:
10
1 - 8 of 8
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help